{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:34:25Z","timestamp":1793316865409,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus is a rare lifelong multi-systemic autoimmune condition. Juvenile-onset SLE (JSLE) is recognized to have a more active disease course when compared with adult-onset disease and patients have a worse long-term survival. Kidney involvement occurs in over 50% of children and treatment decisions are guided by the histological classification. Several international groups have produced treatment protocols that rely on an intense period of immunosuppression to halt the acute kidney inflammatory process, followed by maintenance therapy with close observation for disease improvement and prompt evaluation of disease flares. A reduced glomerular filtration rate at presentation is predictive of later stage chronic kidney disease (CKD) in multivariate analysis. Kidney remission remains suboptimal with only 40\u201360% of patients achieving complete remission. Kidney flares are seen in over a third of patients. The rate of CKD 5 is reported to be up to 15% and the presence of lupus nephritis (LN) has an established link with an associated increase in mortality. In established kidney failure, transplantation seems to be the optimal kidney replacement modality for this group of patients, ideally after a period of disease quiescence. Modified outcome measures in clinical trials have demonstrated that biologic agents can be effective in this disease. Current biologic agents under investigation include obinutuzimab, belimumab, atacicept, anifrolumab, tocilizumab, eculizumab, dapirolizumab, and abatacept. Future research should focus on discovering early disease biomarkers, including surrogates for later cardiovascular disease, and evaluating biological agents as adjuncts to improve the rates of complete remission and subsequently influence the kidney outcome. The aim of this review article is to summarize the current kidney outcomes for this disease with a view to identifying key areas that may help to reduce the risk of long-term CKD.<\/jats:p>","DOI":"10.1007\/s00467-020-04686-1","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T16:02:48Z","timestamp":1595952168000},"page":"1377-1385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Kidney outcomes for children with lupus nephritis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-2390","authenticated-orcid":false,"given":"Louise","family":"Oni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael D","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"issue":"1","key":"4686_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/art.24091","volume":"61","author":"AO Hersh","year":"2009","unstructured":"Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L et al (2009) Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 61(1):13\u201320","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4686_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1542\/pir.27.9.323","volume":"27","author":"BS Gottlieb","year":"2006","unstructured":"Gottlieb BS, Ilowite NT (2006) Systemic lupus erythematosus in children and adolescents. Pediatr Rev 27(9):323\u2013330","journal-title":"Pediatr Rev"},{"issue":"5","key":"4686_CR3","first-page":"681","volume":"33","author":"V Tsioni","year":"2015","unstructured":"Tsioni V, Andreoli L, Meini A, Frassi M, Raffetti E, Airo P et al (2015) The prevalence and incidence of systemic lupus erythematosus in children and adults: a population-based study in a mountain community in northern Italy. Clin Exp Rheumatol 33(5):681\u2013687","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4686_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/ped.12588","volume":"57","author":"Y Kawasaki","year":"2015","unstructured":"Kawasaki Y, Ohara S, Miyazaki K, Kanno S, Ono A, Suyama K et al (2015) Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan. Pediatr Int 57(4):650\u2013655","journal-title":"Pediatr Int"},{"issue":"1","key":"4686_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0961203314552118","volume":"24","author":"FE Mackie","year":"2015","unstructured":"Mackie FE, Kainer G, Adib N, Boros C, Elliott EJ, Fahy R et al (2015) The national incidence and clinical picture of SLE in children in Australia - a report from the Australian Paediatric Surveillance Unit. Lupus. 24(1):66\u201373","journal-title":"Lupus."},{"issue":"9","key":"4686_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1177\/0961203317690616","volume":"26","author":"SRM Lopes","year":"2017","unstructured":"Lopes SRM, Gormezano NWS, Gomes RC, Aikawa NE, Pereira RMR, Terreri MT et al (2017) Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups. Lupus. 26(9):996\u20131001","journal-title":"Lupus."},{"issue":"11","key":"4686_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4103\/0366-6999.206346","volume":"130","author":"CY Wu","year":"2017","unstructured":"Wu CY, Li CF, Wu QJ, Xu JH, Jiang LD, Gong L et al (2017) Chinese systemic lupus erythematosus treatment and research group registry IX: clinical features and survival of childhood-onset systemic lupus erythematosus in China. Chinese Med J-Peking 130(11):1276\u20131282","journal-title":"Chinese Med J-Peking"},{"issue":"11","key":"4686_CR8","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3899\/jrheum.081141","volume":"36","author":"LT Hiraki","year":"2009","unstructured":"Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED (2009) Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 36(11):2539\u20132546","journal-title":"J Rheumatol"},{"issue":"12","key":"4686_CR9","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1136\/annrheumdis-2017-211663","volume":"76","author":"MG Tektonidou","year":"2017","unstructured":"Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM (2017) Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 76(12):2009\u20132016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4686_CR10","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/art.34410","volume":"64","author":"L Watson","year":"2012","unstructured":"Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE et al (2012) Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort. Arthritis Rheum 64(7):2356\u20132365","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4686_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5152\/eurjrheum.2017.16117","volume":"4","author":"M Samanta","year":"2017","unstructured":"Samanta M, Nandi M, Mondal R, Hazra A, Sarkar S, Sabui T et al (2017) Childhood lupus nephritis: 12 years of experience from a developing country\u2019s perspective. Eur J Rheumatol 4(3):178\u2013183","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"4686_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10067-016-3478-4","volume":"36","author":"RH Sassi","year":"2017","unstructured":"Sassi RH, Hendler JV, Piccoli GF, Gasparin AA, da Silva Chakr RM, Brenol JC et al (2017) Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus. Clin Rheumatol 36(1):89\u201395","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4686_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521\u2013530","journal-title":"Kidney Int"},{"issue":"12","key":"4686_CR14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B et al (2017) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76(12):1965\u20131973","journal-title":"Ann Rheum Dis"},{"key":"4686_CR15","unstructured":"KDIGO Glomerulonephritis Work Group (2012) KDIGO Clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139\u2013274"},{"issue":"6","key":"4686_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/acr.21664","volume":"64","author":"BH Hahn","year":"2012","unstructured":"Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD et al (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64(6):797\u2013808","journal-title":"Arthritis Care Res"},{"issue":"3","key":"4686_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/acr.21558","volume":"64","author":"R Mina","year":"2012","unstructured":"Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N et al (2012) Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res 64(3):375\u2013383","journal-title":"Arthritis Care Res"},{"issue":"11","key":"4686_CR18","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH et al (2012) Joint European League Against Rheumatism and European renal association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71(11):1771\u20131782","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4686_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1191\/0961203303lu259oa","volume":"12","author":"M Zabaleta-Lanz","year":"2003","unstructured":"Zabaleta-Lanz M, Vargas-Arenas RE, Tapanes F, Daboin I, Atahualpa Pinto J, Bianco NE (2003) Silent nephritis in systemic lupus erythematosus. Lupus. 12(1):26\u201330","journal-title":"Lupus."},{"issue":"11","key":"4686_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/0961203317706558","volume":"26","author":"L Oni","year":"2017","unstructured":"Oni L, Beresford MW, Witte D, Chatzitolios A, Sebire N, Abulaban K et al (2017) Inter-observer variability of the histological classification of lupus glomerulonephritis in children. Lupus. 26(11):1205\u20131211","journal-title":"Lupus."},{"issue":"7","key":"4686_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41584-019-0235-5","volume":"15","author":"G Murphy","year":"2019","unstructured":"Murphy G, Isenberg DA (2019) New therapies for systemic lupus erythematosus - past imperfect, future tense. Nat Rev Rheumatol 15(7):403\u2013412","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4686_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C et al (2020) Trial of Anifrolumab in active systemic lupus erythematosus. N Engl J Med 382(3):211\u2013221","journal-title":"N Engl J Med"},{"issue":"5","key":"4686_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3899\/jrheum.161554","volume":"45","author":"JE Davidson","year":"2018","unstructured":"Davidson JE, Fu Q, Ji B, Rao S, Roth D, Magder LS et al (2018) Renal remission status and longterm renal survival in patients with lupus nephritis: a retrospective cohort analysis. J Rheumatol 45(5):671\u2013677","journal-title":"J Rheumatol"},{"issue":"4","key":"4686_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0961203315615220","volume":"25","author":"E Aragon","year":"2016","unstructured":"Aragon E, Resontoc LP, Chan YH, Lau YW, Tan PH, Loh HL et al (2016) Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. Lupus. 25(4):399\u2013406","journal-title":"Lupus."},{"issue":"1","key":"4686_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00467-007-0619-7","volume":"23","author":"M Zappitelli","year":"2008","unstructured":"Zappitelli M, Duffy CM, Bernard C, Gupta IR (2008) Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 23(1):83\u201391","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4686_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/0961203312474084","volume":"22","author":"M Hui","year":"2013","unstructured":"Hui M, Garner R, Rees F, Bavakunji R, Daniel P, Varughese S et al (2013) Lupus nephritis: a 15-year multi-centre experience in the UK. Lupus. 22(3):328\u2013332","journal-title":"Lupus."},{"issue":"7","key":"4686_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.autrev.2019.05.011","volume":"18","author":"A Mageau","year":"2019","unstructured":"Mageau A, Timsit JF, Perrozziello A, Ruckly S, Dupuis C, Bouadma L et al (2019) The burden of chronic kidney disease in systemic lupus erythematosus: a nationwide epidemiologic study. Autoimmun Rev 18(7):733\u2013737","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4686_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/art.40697","volume":"71","author":"N Groot","year":"2019","unstructured":"Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain R et al (2019) Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 71(2):290\u2013301","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4686_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0961203308097570","volume":"18","author":"P Hari","year":"2009","unstructured":"Hari P, Bagga A, Mahajan P, Dinda A (2009) Outcome of lupus nephritis in Indian children. Lupus. 18(4):348\u2013354","journal-title":"Lupus."},{"issue":"5","key":"4686_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/0886022X.2011.573897","volume":"33","author":"S Taheri","year":"2011","unstructured":"Taheri S, Beiraghdar F (2011) Lupus nephritis in Iranian children: a review of 60 patients. Ren Fail 33(5):499\u2013505","journal-title":"Ren Fail"},{"issue":"8","key":"4686_CR31","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00467-006-0052-3","volume":"21","author":"SN Wong","year":"2006","unstructured":"Wong SN, Tse KC, Lee TL, Lee KW, Chim S, Lee KP et al (2006) Lupus nephritis in Chinese children--a territory-wide cohort study in Hong Kong. Pediatr Nephrol 21(8):1104\u20131112","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"4686_CR32","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/ndt\/gfp173","volume":"24","author":"P Vachvanichsanong","year":"2009","unstructured":"Vachvanichsanong P, Dissaneewate P, McNeil E (2009) Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre. Nephrol Dial Transplant 24(9):2729\u20132734","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"4686_CR33","first-page":"502","volume":"110","author":"K Shen","year":"1997","unstructured":"Shen K, Yu Y, Tang Z, Liu Z, Li L (1997) The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases. Chin Med J 110(7):502\u2013507","journal-title":"Chin Med J"},{"issue":"2","key":"4686_CR34","first-page":"70","volume":"37","author":"O Drakoulogkona","year":"2011","unstructured":"Drakoulogkona O, Barbulescu AL, Rica I, Musetescu AE, Ciurea PL (2011) The outcome of patients with lupus nephritis and the impact of cardiovascular risk factors. Curr Health Sci J 37(2):70\u201374","journal-title":"Curr Health Sci J"},{"issue":"1","key":"4686_CR35","first-page":"14","volume":"55","author":"AY Chan","year":"2000","unstructured":"Chan AY, Hooi LS (2000) Outcome of 85 lupus nephritis patients treated with intravenous cyclophosphamide: a single centre 10 year experience. Med J Malaysia 55(1):14\u201320","journal-title":"Med J Malaysia"},{"issue":"4","key":"4686_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jmii.2018.12.010","volume":"52","author":"WT Tsai","year":"2019","unstructured":"Tsai WT, Chang HC, Wang CT, Chiang BL, Lin YT (2019) Long-term outcomes in lupus patients receiving different renal replacement therapy. J Microbiol Immunol Infect 52(4):648\u2013653","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"4686_CR37","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.24776","volume":"60","author":"PI Burgos","year":"2009","unstructured":"Burgos PI, Perkins EL, Pons-Estel GJ, Kendrick SA, Liu JM, Kendrick WT et al (2009) Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum 60(9):2757\u20132766","journal-title":"Arthritis Rheum"},{"key":"4686_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2369-13-81","volume":"13","author":"S Ross","year":"2012","unstructured":"Ross S, Benz K, Sauerstein K, Amann K, Dotsch J, Dittrich K (2012) Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis. BMC Nephrol 13:81","journal-title":"BMC Nephrol"},{"key":"4686_CR39","doi-asserted-by":"publisher","first-page":"104021","DOI":"10.1016\/j.cellimm.2019.104021","volume":"347","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Kono H, Leung PSC, Gershwin ME (2020) Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cell Immunol 347:104021","journal-title":"Cell Immunol"},{"issue":"3","key":"4686_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0961203317725591","volume":"27","author":"ES Park","year":"2018","unstructured":"Park ES, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW (2018) Renal outcome after kidney-transplantation in Korean patients with lupus nephritis. Lupus. 27(3):461\u2013467","journal-title":"Lupus."},{"issue":"8","key":"4686_CR41","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1177\/0961203318770527","volume":"27","author":"JC Ramirez-Sandoval","year":"2018","unstructured":"Ramirez-Sandoval JC, Chavez-Chavez H, Wagner M, Vega-Vega O, Morales-Buenrostro LE, Correa-Rotter R (2018) Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort. Lupus. 27(8):1303\u20131311","journal-title":"Lupus."},{"issue":"5","key":"4686_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0961203319840699","volume":"28","author":"N Abdelrahman","year":"2019","unstructured":"Abdelrahman N, Beresford MW, Leone V, Group UKJ-oSLES (2019) Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients. Lupus. 28(5):667\u2013674","journal-title":"Lupus."},{"issue":"1","key":"4686_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12969-018-0271-8","volume":"16","author":"JKK Sit","year":"2018","unstructured":"Sit JKK, Chan WKY (2018) Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study. Pediatr Rheumatol Online J 16(1):56","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"4686_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semarthrit.2019.05.010","volume":"49","author":"M Heshin-Bekenstein","year":"2019","unstructured":"Heshin-Bekenstein M, Trupin L, Yelin E, von Scheven E, Yazdany J, Lawson EF (2019) Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum 49(2):267\u2013272","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"4686_CR45","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00467-020-04501-x","volume":"35","author":"A Suhlrie","year":"2020","unstructured":"Suhlrie A, Hennies I, Gellermann J, B\u00fcscher A, Hoyer P, Waldegger S et al (2020) Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study. Pediatr Nephrol 35(7):1235\u20131246","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"4686_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0961203319890007","volume":"29","author":"JS Lee","year":"2020","unstructured":"Lee JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S (2020) Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine. Lupus. 29(1):52\u201357","journal-title":"Lupus."},{"issue":"11","key":"4686_CR47","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P et al (2017) European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis 76(11):1788\u20131796","journal-title":"Ann Rheum Dis"},{"key":"4686_CR48","doi-asserted-by":"publisher","unstructured":"Petri M, Elkhalifa M, Li J, Magder LS, Goldman DW (2019) Hydroxychloroquine blood levels predict hydroxychloroquine retinopathy. Arthritis Rheumatol 72: 448-453. https:\/\/doi.org\/10.1002\/art.41121","DOI":"10.1002\/art.41121"},{"issue":"10","key":"4686_CR49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.autrev.2018.04.007","volume":"17","author":"C Ponticelli","year":"2018","unstructured":"Ponticelli C, Escoli R, Moroni G (2018) Does cyclophosphamide still play a role in glomerular diseases? Autoimmun Rev 17(10):1022\u20131027","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4686_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/OGX.0000000000000160","volume":"70","author":"O Oktem","year":"2015","unstructured":"Oktem O, Guzel Y, Aksoy S, Aydin E, Urman B (2015) Ovarian function and reproductive outcomes of female patients with systemic lupus erythematosus and the strategies to preserve their fertility. Obstet Gynecol Surv 70(3):196\u2013210","journal-title":"Obstet Gynecol Surv"},{"issue":"20","key":"4686_CR51","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"KR Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF et al (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 113(20):4834\u20134840","journal-title":"Blood."},{"issue":"5","key":"4686_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.autrev.2019.03.010","volume":"18","author":"S Wijetilleka","year":"2019","unstructured":"Wijetilleka S, Mukhtyar C, Jayne D, Ala A, Bright P, Chinoy H et al (2019) Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: systematic literature review. Autoimmun Rev 18(5):535\u2013541","journal-title":"Autoimmun Rev"},{"issue":"14","key":"4686_CR53","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA et al (2016) Differences in disease phenotype and severity in SLE across age groups. Lupus. 25(14):1542\u20131550","journal-title":"Lupus."},{"issue":"11","key":"4686_CR54","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1177\/0961203318791046","volume":"27","author":"A Aggarwal","year":"2018","unstructured":"Aggarwal A, Phatak S, Srivastava P, Lawrence A, Agarwal V, Misra R (2018) Outcomes in juvenile onset lupus: single center cohort from a developing country. Lupus. 27(11):1867\u20131875","journal-title":"Lupus."},{"issue":"9","key":"4686_CR55","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1177\/0961203318776085","volume":"27","author":"GA Mahmoud","year":"2018","unstructured":"Mahmoud GA, Shahin AA, Zayed HS, Moghazy A, Eissa BM (2018) Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience. Lupus. 27(9):1562\u20131569","journal-title":"Lupus."},{"issue":"3","key":"4686_CR56","first-page":"554","volume":"34","author":"B Abujam","year":"2016","unstructured":"Abujam B, Gupta A, Suri D, Rawat A, Singh S (2016) Trends and predictors of mortality in childhood onset lupus in a single North-Indian centre over 23 years: a retrospective study. Clin Exp Rheumatol 34(3):554\u2013559","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"4686_CR57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10067-016-3509-1","volume":"36","author":"A Fatemi","year":"2017","unstructured":"Fatemi A, Matinfar M, Smiley A (2017) Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. Clin Rheumatol 36(2):343\u2013350","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4686_CR58","first-page":"792","volume":"28","author":"A Harzallah","year":"2017","unstructured":"Harzallah A, Kaaroud H, Hajji M, Mami I, Goucha R, Hamida FB et al (2017) Predictive factors of mortality in a tunisian cohort with systemic lupus erythematosus. Saudi J Kidney Dis Transpl 28(4):792\u2013798","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"4686_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00467-016-3485-3","volume":"32","author":"EM Smith","year":"2017","unstructured":"Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C et al (2017) International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Pediatr Nephrol 32(2):283\u2013295","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4686_CR60","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1046\/j.1523-1755.2000.00272.x","volume":"58","author":"GS Hill","year":"2000","unstructured":"Hill GS, Delahousse M, Nochy D, Tomkiewicz E, Remy P, Mignon F et al (2000) A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 58(3):1160\u20131173","journal-title":"Kidney Int"},{"issue":"2","key":"4686_CR61","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C et al (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55(2):252\u2013262","journal-title":"Rheumatology (Oxford)"},{"issue":"9 Suppl 4","key":"4686_CR62","first-page":"18","volume":"72","author":"S Gordon","year":"2013","unstructured":"Gordon S, Denunzio T, Uy A (2013) Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria. Hawaii J Med Public Health 72(9 Suppl 4):18\u201323","journal-title":"Hawaii J Med Public Health"},{"key":"4686_CR63","unstructured":"clinicaltrials.gov. A study to evaluate the safety and efficacy of obinutuzumab compared with placebo in participants with lupus nephritis (LN). 2015;NCT02550652"},{"issue":"9767","key":"4686_CR64","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 377(9767):721\u2013731","journal-title":"Lancet."},{"issue":"2","key":"4686_CR65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/art.40360","volume":"70","author":"JT Merrill","year":"2018","unstructured":"Merrill JT, Wallace DJ, Wax S, Kao A, Fraser PA, Chang P et al (2018) Efficacy and safety of atacicept in patients with systemic lupus erythematosus: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled, parallel-arm, Phase IIb Study. Arthritis Rheum 70(2):266\u2013276","journal-title":"Arthritis Rheum"},{"key":"4686_CR66","first-page":"article S313","volume":"66","author":"CCL Morehouse","year":"2014","unstructured":"Morehouse CCL, Wang LW et al (2014) Target modulation of a type I interferon (IFN) gene signature with sifalimumab or anifrolumab in SLE patients in two open label phase 2 Japanese trials. Arthritis Rheum 66:article S313","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4686_CR67","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.27221","volume":"62","author":"GG Illei","year":"2010","unstructured":"Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K et al (2010) Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum 62(2):542\u2013552","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4686_CR68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1191\/0961203303lu1021oa","volume":"13","author":"RP Rother","year":"2004","unstructured":"Rother RP, Mojcik CF, McCroskery EW (2004) Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus. Lupus. 13(5):328\u2013334","journal-title":"Lupus."},{"key":"4686_CR69","doi-asserted-by":"crossref","unstructured":"Furie RB, Bruce IN, Dorner T et al (2019) Efficacy and safety of dapirolizumab pegol (DZP) in patients with moderately to severely active systemic lupus erythematosus (SLE): A randomised, placebo (PBO)-controlled study. Annals of the Rheumatic Diseases. 78:775\u2013776","DOI":"10.1136\/annrheumdis-2019-eular.5529"},{"issue":"2","key":"4686_CR70","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/art.38260","volume":"66","author":"R Furie","year":"2014","unstructured":"Furie R, Nicholls K, Cheng TT, Houssiau F, Burgos-Vargas R, Chen SL et al (2014) Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheum 66(2):379\u2013389","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4686_CR71","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1177\/0961203318785245","volume":"27","author":"G Chehab","year":"2018","unstructured":"Chehab G, Sauer GM, Richter JG, Brinks R, Willers R, Fischer-Betz R et al (2018) Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort. Lupus. 27(10):1652\u20131660","journal-title":"Lupus."},{"issue":"6","key":"4686_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2223\/JPED.2227","volume":"88","author":"VM Bugni","year":"2012","unstructured":"Bugni VM, Ozaki LS, Okamoto KY, Barbosa CM, Hilario MO, Len CA et al (2012) Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases. J Pediatr 88(6):483\u2013488","journal-title":"J Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04686-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T16:35:35Z","timestamp":1650213335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4686"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04686-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The views expressed are those of the authors and not necessarily those of the NHS, respective Universities, NIHR, or Department of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}